SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013831
Filing Date
2022-08-22
Accepted
2022-08-22 07:08:50
Documents
109
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20220630x10q.htm   iXBRL 10-Q 2915058
2 EX-31.1 jagx-20220630xex31d1.htm EX-31.1 11014
3 EX-31.2 jagx-20220630xex31d2.htm EX-31.2 11013
4 EX-32.1 jagx-20220630xex32d1.htm EX-32.1 6960
5 EX-32.2 jagx-20220630xex32d2.htm EX-32.2 6935
  Complete submission text file 0001558370-22-013831.txt   13473019

Data Files

Seq Description Document Type Size
6 EX-101.SCH jagx-20220630.xsd EX-101.SCH 118554
7 EX-101.CAL jagx-20220630_cal.xml EX-101.CAL 69220
8 EX-101.DEF jagx-20220630_def.xml EX-101.DEF 583500
9 EX-101.LAB jagx-20220630_lab.xml EX-101.LAB 833846
10 EX-101.PRE jagx-20220630_pre.xml EX-101.PRE 765608
103 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20220630x10q_htm.xml XML 2348871
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 221182203
SIC: 2834 Pharmaceutical Preparations